SARS-CoV-2 reinfection and COVID-19 severity-Reference-Cited by-同舟云学术

SARS-CoV-2 reinfection and COVID-19 severity

Published:2022-03-21 Issue:1 Volume:11 Page:894-901
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Nguyen Nhu Ngoc¹²,Houhamdi Linda¹²,Hoang Van Thuan³,Delerce Jeremy²⁴,Delorme Léa¹²,Colson Philippe²⁴,Brouqui Philippe²⁴,Fournier Pierre-Edouard¹²,Raoult Didier²⁴,Gautret Philippe¹²

Affiliation:

1. IRD, AP-HM, SSA, VITROME, Aix Marseille University, Marseille, France

2. IHU-Méditerranée Infection, Marseille, France

3. Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam

4. IRD, AP-HM, MEPHI, Aix-Marseille University, Marseille, France

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2052358

Reference25 articles.

1. World Health Organization. COVID-19 natural immunity. 2021 [cited 2021 Nov 18]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Natural_immunity-2021.1.

2. Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

3. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

4. SARS-CoV-2 reinfection in patients negative for immunoglobulin G following recovery from COVID-19

5. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID‐19: A systematic review and meta‐analysis

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the risk of SARS-CoV-2 reinfection with the Omicron or Delta variant in Wales, UK;PLOS ONE;2024-09-06

2. A mathematical model for the within-host (re)infection dynamics of SARS-CoV-2;Mathematical Biosciences;2024-05

3. Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study;The Lancet Infectious Diseases;2024-05

4. Clinical Characteristics of COVID-19 Reinfection: A Retrospective Study in China;2024-04-08

5. The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study;BMC Infectious Diseases;2024-03-27